ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

DCBDC Advisors Ok Training Grant Program In Clinical Oncology

February 22, 1991

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014